Genetically engineered mouse models of mammary intraepithelial neoplasia

被引:51
作者
Cardiff, RD
Moghanaki, D
Jensen, RA
机构
[1] Univ Calif Davis, Dept Pathol, Davis, CA 95616 USA
[2] Univ Calif Davis, Ctr Comparat Med, Davis, CA 95616 USA
[3] Univ Calif San Diego, Ctr Canc, Sch Med, La Jolla, CA 92093 USA
[4] Vanderbilt Univ, Med Ctr, Dept Pathol, Nashville, TN 37232 USA
基金
美国国家卫生研究院;
关键词
focality; atypia; association; dysplasia;
D O I
10.1023/A:1009534129331
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Foci of atypical mammary epithelium have been associated with breast cancer in many species including mouse and man. The advent of targeted genomics has led to the creation of numerous genetically engineered mice (GEM)(5) which display focal atypical lesions associated with mammary cancer. Some early lesions in GEM have a remarkable morphological similarity to pre-cancers in humans. While the malignant potential of atypical foci have been thoroughly documented in the non-GEM by tissue transplantation, a review of the literature reveals that precursor lesions in GEM remain incompletely described and only partially documented. Their validation as appropriate models of human breast preneoplasia awaits classical transplantation studies. Here, we review the literature characterizing early lesions of GEM models of mammary cancer, discuss the principles of the Focality, Atypia, and Association and present an introduction of mammary transplantation for model Validation.
引用
收藏
页码:421 / 437
页数:17
相关论文
共 127 条
[1]  
AMUNDADOTTIR LT, 1995, CELL GROWTH DIFFER, V6, P737
[2]   Transgenic mouse models of breast cancer [J].
Amundadottir, LT ;
Merlino, G ;
Dickson, RB .
BREAST CANCER RESEARCH AND TREATMENT, 1996, 39 (01) :119-135
[3]   Amplification of the neu/erbB-2 oncogene in a mouse model of mammary tumorigenesis [J].
Andrechek, ER ;
Hardy, WR ;
Siegel, PM ;
Rudnicki, MA ;
Cardiff, RD ;
Muller, WJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (07) :3444-3449
[4]   HA-RAS ONCOGENE EXPRESSION DIRECTED BY A MILK PROTEIN GENE PROMOTER - TISSUE-SPECIFICITY, HORMONAL-REGULATION, AND TUMOR-INDUCTION IN TRANSGENIC MICE [J].
ANDRES, AC ;
SCHONENBERGER, CA ;
GRONER, B ;
HENNIGHAUSEN, L ;
LEMEUR, M ;
GERLINGER, P .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1987, 84 (05) :1299-1303
[5]   HA-RAS AND C-MYC ONCOGENE EXPRESSION INTERFERES WITH MORPHOLOGICAL AND FUNCTIONAL-DIFFERENTIATION OF MAMMARY EPITHELIAL-CELLS IN SINGLE AND DOUBLE TRANSGENIC MICE [J].
ANDRES, AC ;
VANDERVALK, MA ;
SCHONENBERGER, CA ;
FLUCKIGER, F ;
LEMEUR, M ;
GERLINGER, P ;
GRONER, B .
GENES & DEVELOPMENT, 1988, 2 (11) :1486-1495
[6]  
Bocchinfuso WP, 1999, CANCER RES, V59, P1869
[7]   Interleukin 12-mediated prevention of spontaneous mammary adenocarcinomas in two lines of HER-2/neu transgenic mice [J].
Boggio, K ;
Nicoletti, G ;
Di Carlo, E ;
Cavallo, F ;
Landuzzi, L ;
Melani, C ;
Giovarelli, M ;
Rossi, I ;
Nanni, P ;
De Giovanni, C ;
Bouchard, P ;
Wolf, S ;
Modesti, A ;
Musiani, P ;
Lollini, PL ;
Colombo, MP ;
Forni, G .
JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 188 (03) :589-596
[8]   Induction of mammary gland hyperplasia and carcinomas in transgenic mice expressing human cyclin E [J].
Bortner, DM ;
Rosenberg, MP .
MOLECULAR AND CELLULAR BIOLOGY, 1997, 17 (01) :453-459
[9]  
BORTNER DM, 1995, CELL GROWTH DIFFER, V6, P1579
[10]   STOCHASTIC APPEARANCE OF MAMMARY-TUMORS IN TRANSGENIC MICE CARRYING THE MMTV/C-NEU ONCOGENE [J].
BOUCHARD, L ;
LAMARRE, L ;
TREMBLAY, PJ ;
JOLICOEUR, P .
CELL, 1989, 57 (06) :931-936